139 related articles for article (PubMed ID: 9329759)
1. Effect of oral antidiabetics and insulin on lipids and coronary heart disease in non-insulin-dependent diabetes mellitus.
Hanefeld M; Temelkova-Kurktschiev T; Köhler C
Ann N Y Acad Sci; 1997 Sep; 827():246-68. PubMed ID: 9329759
[No Abstract] [Full Text] [Related]
2. [Oral antidiabetics and lipids].
Verges B
Ann Endocrinol (Paris); 2002 Apr; 63(2 Pt 2):1S45-50. PubMed ID: 12037508
[TBL] [Abstract][Full Text] [Related]
3. [Progress in therapy for diabetes mellitus--insulin therapy combined with oral hypoglycemic agents( basal supported oral therapy)].
Yoshioka N
Nihon Naika Gakkai Zasshi; 2009 Apr; 98(4):756-60. PubMed ID: 19472527
[No Abstract] [Full Text] [Related]
4. Insulin and oral hypoglycemic agents should not be used in combination in the treatment of type 2 diabetes.
Westphal SA; Palumbo PJ
Arch Intern Med; 2003 Aug 11-25; 163(15):1783-5; discussion 1785. PubMed ID: 12912711
[No Abstract] [Full Text] [Related]
5. [Which treatment can be proposed to a diabetic patient presenting with secondary failure of oral antidiabetics?].
Blanc MH; Galtier-Dereure F; Parer-Richard C; Bringer J; Jaffiol C
Rev Med Suisse Romande; 1993 Nov; 113(11):955-61. PubMed ID: 8272722
[No Abstract] [Full Text] [Related]
6. Switching from an oral regimen to insulin in diabetes.
Perry M
Community Nurse; 2000 May; 6(4):27-8. PubMed ID: 12778520
[No Abstract] [Full Text] [Related]
7. [When oral antidiabetics are no longer enough. Tablets plus basal insulin].
Meissner T
MMW Fortschr Med; 2001 Aug; 143(31-32):46. PubMed ID: 11556193
[No Abstract] [Full Text] [Related]
8. Influence of the glucose-lowering rate on left ventricular function in patients with type 2 diabetes and coronary heart disease.
Wu W; Sun Z; Li Q; Wang M; Miao J; Zheng Z; Sun L; Huang J; Wang Y; Zhang H; Hu C
J Diabetes Complications; 2012; 26(2):83-8. PubMed ID: 22475635
[TBL] [Abstract][Full Text] [Related]
9. [Practical points in the use of insulin and oral hypoglycemic agents].
Nakayama H
Hokkaido Igaku Zasshi; 1989 Jul; 64(4):387-90. PubMed ID: 2684832
[No Abstract] [Full Text] [Related]
10. Adherence to treatment for diabetes mellitus: validation of instruments for oral antidiabetics and insulin.
Boas LC; Lima ML; Pace AE
Rev Lat Am Enfermagem; 2014; 22(1):11-8. PubMed ID: 24553698
[TBL] [Abstract][Full Text] [Related]
11. [Approaches in diabetes therapy. 2. Selection and use of oral antidiabetics. 1) Drugs enhancing insulin secretion].
Yoshimoto K; Ishida H
Nihon Naika Gakkai Zasshi; 2000 Aug; 89(8):1523-9. PubMed ID: 11062899
[No Abstract] [Full Text] [Related]
12. [Combined therapy with insulin and oral hypoglycemic agents in diabetes mellitus].
Takamatsu J
Nihon Rinsho; 1990 Dec; 48 Suppl():1031-7. PubMed ID: 2086864
[No Abstract] [Full Text] [Related]
13. Coronary circulatory function abnormalities in insulin resistance: insights from positron emission tomography.
Schelbert HR
J Am Coll Cardiol; 2009 Feb; 53(5 Suppl):S3-8. PubMed ID: 19179215
[TBL] [Abstract][Full Text] [Related]
14. Addition of insulin to oral therapy in type 2 diabetes.
Dağdelen S
N Engl J Med; 2008 Mar; 358(11):1197; author reply 1198. PubMed ID: 18337612
[No Abstract] [Full Text] [Related]
15. Timely addition of insulin to oral therapy for type 2 diabetes.
Riddle MC
Diabetes Care; 2002 Feb; 25(2):395-6. PubMed ID: 11815517
[No Abstract] [Full Text] [Related]
16. [Approach to diabetes therapy. 2. Selection and the use of oral antidiabetics. 2) Agents to correct insulin resistance].
Kashiwagi A; Maegawa H
Nihon Naika Gakkai Zasshi; 2000 Aug; 89(8):1530-5. PubMed ID: 11062900
[No Abstract] [Full Text] [Related]
17. Determinants of response to insulin therapy following failure of oral agents in type 2 diabetes.
Karalliedde J; Smith A; Viberti G
Diabetes Care; 2005 Oct; 28(10):2589-90. PubMed ID: 16186308
[No Abstract] [Full Text] [Related]
18. [Combination therapy of oral hypoglycemic agents which enhance the efficacy of insulin therapy].
Hirose T
Nihon Rinsho; 2012 May; 70 Suppl 3():669-77. PubMed ID: 22768596
[No Abstract] [Full Text] [Related]
19. [Effect of propranolol on the indicators of carbohydrate metabolism and lipid transport in patients with diabetes mellitus type 2].
Filatova NP; Ostrovskaia TP; Novikov AV; Iliushina IP; Olfer'ev AM
Probl Endokrinol (Mosk); 1988; 34(1):5-9. PubMed ID: 3283727
[TBL] [Abstract][Full Text] [Related]
20. Oral hypoglycaemic agents. When, how and why.
Harris P; Colagiuri S
Aust Fam Physician; 1997 Apr; 26(4):391-6. PubMed ID: 9115112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
